Recent data has suggested that health care-associated pneumonia (HCAP) criteria has a poor predictive value in determining risk for drug resistant pathogens (DRPs) and has led to increased use of broad-spectrum antibiotics. The Drug Resistance in Pneumonia (DRIP) score includes a more selective set of criteria to predict pneumonia risk due to DRPs if a score of $ 4 is calculated. Recent validation studies performed at the local level have shown conflicting results on the impact of antibiotic selection if a DRIP score was used to guide antibiotic prescribing.
Rationale Recent data suggest that health care–associated pneumonia (HCAP) criteria has poor predictive value in determining risk for drug-resistant pathogens (DRPs) and leads to increased use of broad-spectrum antibiotics. The Drug Resistance in Pneumonia (DRIP) Score highlights a selective set of criteria to predict pneumonia risk. Validation studies show conflicting results on the impact of antibiotic selection based on the DRIP score. Methods This was a retrospective chart review of hospitalized patients from March 2018 to April 2018 who were started on antibiotics for a respiratory tract infection. The HCAP criteria and DRIP scores were calculated and antibiotic selection was analyzed. The primary focus was to determine if utilization of the DRIP score could modify antipseudomonal beta-lactam (APBL) prescribing patterns. Results A total of 82 patients were included in the study. Sixty-four (78%) patients had a DRIP score <4 with 19 (30%) receiving an APBL. There were 18 patients with a DRIP score >4, and 7 (39%) patients received non-APBL antibiotics. The HCAP criteria and subsequent prescribing was also analyzed. Forty-nine patients were identified as not meeting HCAP criteria. Of these patients, 12 (24%) received APBL. Thirty-three patients met HCAP criteria, and 15 (45%) received a non-APBL. If HCAP criteria were used to guide antibiotic prescribing, we would see a net increase of 3% in APBL use; whereas if DRIP scores were implemented, we would see a net decrease of 14% in APBL use. Conclusions Our study indicates that implementation of the DRIP score would result in decreased empiric APBL use.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.